600329.SH
Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 35.72
+1.05%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 25.75x
- P/E 2027E
- 22.41x
- P/E 2028E
- 20.18x
- P/S forward
- 9.89x
Trailing multiples
Trailing twelve months
- P/E TTM
- 12.91x
- PEG TTM
- 0.46x
- Price / book
- 4.63x
- Price / sales
- 5.34x
- Price / cash flow
- 50.36x
Enterprise value
- Enterprise value
- CNY 25.7B
- EV / sales
- 5.17x
- EV / EBITDA
- 9.85x
- EV / EBIT
- 10.11x
- Market cap
- CNY 27.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026